Pub Date : 2024-12-10DOI: 10.1016/j.semerg.2024.102401
Mónica Regalado Chamorro , Aldo Medina Gamero
{"title":"Resiliencia en niños con cáncer: un recurso para su salud mental","authors":"Mónica Regalado Chamorro , Aldo Medina Gamero","doi":"10.1016/j.semerg.2024.102401","DOIUrl":"10.1016/j.semerg.2024.102401","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102401"},"PeriodicalIF":0.9,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-10DOI: 10.1016/j.semerg.2024.102391
F.M. Escandell Rico , L. Pérez Fernández
Low influenza vaccination rates among specific risk groups contribute to the burden of disease and remain a major public health challenge. Therefore, the purpose of this review was to provide the most recent evidence on the determinants of influenza vaccination in people over 65 years of age. During the review process, we followed the recommendations for PRISMA systematic reviews. The bibliographic search was carried out in databases Cumulative Index to Nursing and Allied Health Literature (CINAHL), SCOPUS, MedLine / PubMed, Cochrane, Google Scholar, with free and controlled language and the search terms MeSh: Vaccination Coverage, Health Communication, Aged, Influenza Vaccines by combining them with the Boolean operators AND and OR. The search was limited to articles published between 2019-2024. Seven original research articles were included, of which observational and cross-sectional studies were identified as the main type of study. The topic of study represents education, the recruitment of the vulnerable population and the detection of sociodemographic factors that affect vaccination coverage. The findings of this review suggest that it would be beneficial to take into account communication, education and recruitment as determining factors of influenza vaccination in those over 65 years of age. In this sense, effective strategies could be implemented to increase vaccination coverage in the most vulnerable population and improve future vaccination campaigns.
{"title":"Factores determinantes de la vacunación antigripal en mayores de 65 años: una revisión sistemática","authors":"F.M. Escandell Rico , L. Pérez Fernández","doi":"10.1016/j.semerg.2024.102391","DOIUrl":"10.1016/j.semerg.2024.102391","url":null,"abstract":"<div><div>Low influenza vaccination rates among specific risk groups contribute to the burden of disease and remain a major public health challenge. Therefore, the purpose of this review was to provide the most recent evidence on the determinants of influenza vaccination in people over 65<!--> <!-->years of age. During the review process, we followed the recommendations for PRISMA systematic reviews. The bibliographic search was carried out in databases Cumulative Index to Nursing and Allied Health Literature (CINAHL), SCOPUS, MedLine / PubMed, Cochrane, Google Scholar, with free and controlled language and the search terms MeSh: Vaccination Coverage, Health Communication, Aged, Influenza Vaccines by combining them with the Boolean operators AND and OR. The search was limited to articles published between 2019-2024. Seven original research articles were included, of which observational and cross-sectional studies were identified as the main type of study. The topic of study represents education, the recruitment of the vulnerable population and the detection of sociodemographic factors that affect vaccination coverage. The findings of this review suggest that it would be beneficial to take into account communication, education and recruitment as determining factors of influenza vaccination in those over 65<!--> <!-->years of age. In this sense, effective strategies could be implemented to increase vaccination coverage in the most vulnerable population and improve future vaccination campaigns.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102391"},"PeriodicalIF":0.9,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-10DOI: 10.1016/j.semerg.2024.102393
M. Frías Vargas , N. Fontanillas Gamilla , I. Rivera Panizo , D. Fuertes Domínguez , C. Granja Ortega , J.F. Peiró Morant , en nombre del Grupo de Trabajo de Vasculopatías y de Aparato Digestivo de SEMERGEN
Introduction
Hemorrhoidal disease (HD) is a public health problem in our clinics and in the quality of life of patients, therefore it is necessary to analyze the actions in the management of HD by healthcare professionals in Spain.
Material and methods
Observational, descriptive and cross-sectional study with data collection through a 28-question survey using a Google® form. 240 surveys were received. Quantitative variables were represented with means and standard deviation and qualitative variables with percentages.
Results
Two hundred and forty surveys were analyzed. Sixty-five percent of respondents were women, with a mean age of 48 ± 12 years. Ninety-three percent of the professionals had 21-30 years of clinical experience, with more than 70% being family physicians. Fifty-nine percent considered that HD is adequately diagnosed in primary care, but there was a negative impact on follow-up during the COVID-19 pandemic, as 90% considered it inadequate. Forty-two percent of participants were not familiar with the Goligher classification, while 20% knew it and used it in their practice. The most commonly prescribed combination was the use of topical corticosteroids, bulk-forming laxatives, phlebotonics or venoactive drugs, and non-pharmacological measures (12.1%), with diosmin/hesperidin being the most prescribed venoactive agent (63%). Thirty-nine point six percent stated that HD is undertreated. Eighty-nine percent of physicians acknowledged not using any algorithm or protocol for the diagnosis, treatment, and follow-up of HD in their practice, and 89% stated that they were not trained in their workplaces. Seventy-five percent of doctors believed that one of the main limitations hindering the follow-up of the disease was the lack of time during consultations.
Conclusions
Approximately 3 out of 5 professionals believe they adequately manage HD, and only 1 out of 5 respondents acknowledge knowing and using the Goligher classification in their clinical practice. Furthermore, 2 out of 5 assert that HD is undertreated in primary care. The prescription patterns for HD are heterogeneous, involving multiple combinations. The vast majority of professionals do not follow any established protocol for managing the disease. The survey highlights the need for training our professionals in the diagnosis, treatment, and follow-up of HD to ensure that our patients receive the highest possible quality of healthcare.
{"title":"Percepción y conocimiento de la enfermedad hemorroidal en los profesionales sanitarios en España","authors":"M. Frías Vargas , N. Fontanillas Gamilla , I. Rivera Panizo , D. Fuertes Domínguez , C. Granja Ortega , J.F. Peiró Morant , en nombre del Grupo de Trabajo de Vasculopatías y de Aparato Digestivo de SEMERGEN","doi":"10.1016/j.semerg.2024.102393","DOIUrl":"10.1016/j.semerg.2024.102393","url":null,"abstract":"<div><h3>Introduction</h3><div>Hemorrhoidal disease (HD) is a public health problem in our clinics and in the quality of life of patients, therefore it is necessary to analyze the actions in the management of HD by healthcare professionals in Spain.</div></div><div><h3>Material and methods</h3><div>Observational, descriptive and cross-sectional study with data collection through a 28-question survey using a Google® form. 240 surveys were received. Quantitative variables were represented with means and standard deviation and qualitative variables with percentages.</div></div><div><h3>Results</h3><div>Two hundred and forty surveys were analyzed. Sixty-five percent of respondents were women, with a mean age of 48<!--> <!-->±<!--> <!-->12<!--> <!-->years. Ninety-three percent of the professionals had 21-30<!--> <!-->years of clinical experience, with more than 70% being family physicians. Fifty-nine percent considered that HD is adequately diagnosed in primary care, but there was a negative impact on follow-up during the COVID-19 pandemic, as 90% considered it inadequate. Forty-two percent of participants were not familiar with the Goligher classification, while 20% knew it and used it in their practice. The most commonly prescribed combination was the use of topical corticosteroids, bulk-forming laxatives, phlebotonics or venoactive drugs, and non-pharmacological measures (12.1%), with diosmin/hesperidin being the most prescribed venoactive agent (63%). Thirty-nine point six percent stated that HD is undertreated. Eighty-nine percent of physicians acknowledged not using any algorithm or protocol for the diagnosis, treatment, and follow-up of HD in their practice, and 89% stated that they were not trained in their workplaces. Seventy-five percent of doctors believed that one of the main limitations hindering the follow-up of the disease was the lack of time during consultations.</div></div><div><h3>Conclusions</h3><div>Approximately 3 out of 5 professionals believe they adequately manage HD, and only 1 out of 5 respondents acknowledge knowing and using the Goligher classification in their clinical practice. Furthermore, 2 out of 5 assert that HD is undertreated in primary care. The prescription patterns for HD are heterogeneous, involving multiple combinations. The vast majority of professionals do not follow any established protocol for managing the disease. The survey highlights the need for training our professionals in the diagnosis, treatment, and follow-up of HD to ensure that our patients receive the highest possible quality of healthcare.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102393"},"PeriodicalIF":0.9,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.semerg.2024.102388
A. García Tévar, M.T. Herrero Ezquerro
Objectives
To quantify parkinsonian patients in the Region of Murcia (RM), their health areas and zones, and find their prevalences and percentages.
Material and methods
All RM patients registered in Primary Care of the Murcian Health Service with the CIAP-2 code N87 were included. We calculated number, prevalence and percentages by age and sex groups, means and age ranges and years of evolution. The study was carried out at the age of diagnosis and at the age of data collection, analyzing their differences.
Results
We obtained 3050 parkinsonian patients (1476 men and 1574 women) with respective prevalences of 206.09 cases per 100,000 inhabitants (206.09/105), 199.06/105 and 213.15/105, not significant differences by sex or in number of patients (p = 0.79) or in prevalence (P = .52). By age group, prevalences were higher in men (P < .05) between 50 and 99 years of age (not between 90 and 94 and ≥ 100 years). Of the 9 Health Areas, the highest prevalences were in areas IV Northwest, with 322.31/105, and V Altiplano, with 304.30/105, and the lowest prevalence, of 171.13/105, was observed in Area VII Murcia East (P < .05). Of the 85 Health Zones, the one with the highest prevalence was Lorca-La Paca, with 510.51/105, and the one with the lowest Murcia-Zarandona, with 78.48/105 (P < .05).
Conclusions
First demographic and detailed prevalence study of parkinsonism in the RM. The prevalence in RM was 206.09/105. By health areas, the highest prevalences were in the Northwest and Altiplano and by health areas a prevalence of 510.51/105 stood out. This work aims to be useful to facilitate resource planning, with consequent better health care.
目的：量化穆尔西亚地区（RM）帕金森病患者及其健康区域和区域，了解其患病率和百分比。材料和方法：纳入所有在Murcian Health Service初级保健中心登记的、CIAP-2代码N87的RM患者。我们根据年龄和性别群体、平均值和年龄范围以及进化年限计算了数量、患病率和百分比。本研究分别在诊断年龄和数据收集年龄进行，分析其差异。结果：我们获得3050例帕金森病患者（男性1476例，女性1574例），患病率分别为206.09例/10万居民（206.09/105）、199.06/105和213.15/105，在性别、患者数量和患病率方面无显著差异（p=0.79）。按年龄组划分，男性患病率较高（P5）， VAltiplano患病率为304.30/105，VIIMurcia东部地区患病率最低，为171.13/105，Murcia-Zarandona患病率最低，为78.48/105 (p)结论：首次对RM帕金森病进行人口统计学和详细患病率研究。RM患病率为206.09/105。按卫生地区划分，发病率最高的是西北部和高原地区，按卫生地区划分，发病率为510.51/105。这项工作旨在有助于促进资源规划，从而改善保健。
{"title":"Estudio demográfico y de prevalencia del parkinsonismo en la región de Murcia","authors":"A. García Tévar, M.T. Herrero Ezquerro","doi":"10.1016/j.semerg.2024.102388","DOIUrl":"10.1016/j.semerg.2024.102388","url":null,"abstract":"<div><h3>Objectives</h3><div>To quantify parkinsonian patients in the Region of Murcia (RM), their health areas and zones, and find their prevalences and percentages.</div></div><div><h3>Material and methods</h3><div>All RM patients registered in Primary Care of the Murcian Health Service with the CIAP-2 code N87 were included. We calculated number, prevalence and percentages by age and sex groups, means and age ranges and years of evolution. The study was carried out at the age of diagnosis and at the age of data collection, analyzing their differences.</div></div><div><h3>Results</h3><div>We obtained 3050 parkinsonian patients (1476 men and 1574 women) with respective prevalences of 206.09 cases per 100,000 inhabitants (206.09/10<sup>5</sup>), 199.06/10<sup>5</sup> and 213.15/10<sup>5</sup>, not significant differences by sex or in number of patients (p<!--> <!-->=<!--> <!-->0.79) or in prevalence (<em>P</em> <!-->=<!--> <!-->.52). By age group, prevalences were higher in men (<em>P</em> <!--><<!--> <!-->.05) between 50 and 99<!--> <!-->years of age (not between 90 and 94 and ≥<!--> <!-->100<!--> <!-->years). Of the 9 Health Areas, the highest prevalences were in areas IV<!--> <!-->Northwest, with 322.31/10<sup>5</sup>, and V<!--> <!-->Altiplano, with 304.30/10<sup>5</sup>, and the lowest prevalence, of 171.13/10<sup>5</sup>, was observed in Area VII<!--> <!-->Murcia East (<em>P</em> <!--><<!--> <!-->.05). Of the 85 Health Zones, the one with the highest prevalence was Lorca-La Paca, with 510.51/10<sup>5</sup>, and the one with the lowest Murcia-Zarandona, with 78.48/10<sup>5</sup> (<em>P</em> <!--><<!--> <!-->.05).</div></div><div><h3>Conclusions</h3><div>First demographic and detailed prevalence study of parkinsonism in the RM. The prevalence in RM was 206.09/10<sup>5</sup>. By health areas, the highest prevalences were in the Northwest and Altiplano and by health areas a prevalence of 510.51/10<sup>5</sup> stood out. This work aims to be useful to facilitate resource planning, with consequent better health care.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 2","pages":"Article 102388"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.semerg.2024.102333
F.A. Butt , M. Nunez-Nunez , B. Juhász , A. Bueno-Cavanillas , K.S. Khan
Background
Randomised clinical trials (RCTs) hold the highest validity level in effectiveness research. However, there is a growing concern regarding their trustworthiness. We aimed to appraise the quality and reporting of recommendation documents regarding research integrity to describe their contribution towards fostering RCT integrity.
Methods
Following prospective registration (https://doi.org/10.17605/OSF.IO/DN93K), searches of electronic databases (Scopus, PubMed, Google Scholar) and relevant websites were performed from inception to 30 July 2023 without language limitations. Data extraction and document appraisal using adapted versions of AGREE II, RIGHT and ACCORD checklists were carried out in duplicate. Appraisal data were synthesised as % of the maximum score and documents were classified as: good ≥ 70%, average 50–69%, and poor < 50%.
Results
From 1310 citations 14 recommendation documents were selected. Of these, 11 documents (78%) were of poor quality according to all three appraisal checklists. Reviewer agreement was 86–100% regarding the checklist items. The top three documents were: “International multi-stakeholder consensus statement on clinical trial integrity” (score 70% on AGREE II, 96% on RIGHT and 88% on ACCORD); “Development of consensus on essential virtues for ethics and research integrity” (score 51% on AGREE II, 71% on RIGHT and 77% on ACCORD); and “Hong Kong principles for assessing researchers” (score 19% on AGREE II, 57% on RIGHT and 10% on ACCORD).
Conclusion
There is a room from improvement in the quality and reporting of recommendation documents to help fostering RCT integrity. All stakeholders in the RCT lifecycle making concerted efforts to improve trust in evidence-based medicine need robust guidance to underpin research integrity policies and guidelines.
{"title":"The quality and reporting of recommendation documents to enhance the integrity of clinical trials: A systematic review and critical appraisal","authors":"F.A. Butt , M. Nunez-Nunez , B. Juhász , A. Bueno-Cavanillas , K.S. Khan","doi":"10.1016/j.semerg.2024.102333","DOIUrl":"10.1016/j.semerg.2024.102333","url":null,"abstract":"<div><h3>Background</h3><div>Randomised clinical trials (RCTs) hold the highest validity level in effectiveness research. However, there is a growing concern regarding their trustworthiness. We aimed to appraise the quality and reporting of recommendation documents regarding research integrity to describe their contribution towards fostering RCT integrity.</div></div><div><h3>Methods</h3><div>Following prospective registration (<span><span>https://doi.org/10.17605/OSF.IO/DN93K</span><svg><path></path></svg></span>), searches of electronic databases (Scopus, PubMed, Google Scholar) and relevant websites were performed from inception to 30 July 2023 without language limitations. Data extraction and document appraisal using adapted versions of AGREE II, RIGHT and ACCORD checklists were carried out in duplicate. Appraisal data were synthesised as % of the maximum score and documents were classified as: good<!--> <!-->≥<!--> <!-->70%, average 50–69%, and poor<!--> <!--><<!--> <!-->50%.</div></div><div><h3>Results</h3><div>From 1310 citations 14 recommendation documents were selected. Of these, 11 documents (78%) were of poor quality according to all three appraisal checklists. Reviewer agreement was 86–100% regarding the checklist items. The top three documents were: “<em>International multi-stakeholder consensus statement on clinical trial integrity</em>” (score 70% on AGREE II, 96% on RIGHT and 88% on ACCORD); “<em>Development of consensus on essential virtues for ethics and research integrity</em>” (score 51% on AGREE II, 71% on RIGHT and 77% on ACCORD); and “<em>Hong Kong principles for assessing researchers</em>” (score 19% on AGREE II, 57% on RIGHT and 10% on ACCORD).</div></div><div><h3>Conclusion</h3><div>There is a room from improvement in the quality and reporting of recommendation documents to help fostering RCT integrity. All stakeholders in the RCT lifecycle making concerted efforts to improve trust in evidence-based medicine need robust guidance to underpin research integrity policies and guidelines.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 2","pages":"Article 102333"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.semerg.2024.102402
S. Torres-Conde , F. Buitrago-Ramírez
{"title":"Guía ESC 2023 sobre el manejo de la enfermedad cardiovascular en pacientes con diabetes: lagunas en las categorías de riesgo cardiovascular","authors":"S. Torres-Conde , F. Buitrago-Ramírez","doi":"10.1016/j.semerg.2024.102402","DOIUrl":"10.1016/j.semerg.2024.102402","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102402"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.semerg.2024.102352
A. Medina-Cobos , A. Cabrerizo-Carvajal , R. Ruiz-Villaverde
{"title":"Escombroidosis. Un diagnóstico a considerar","authors":"A. Medina-Cobos , A. Cabrerizo-Carvajal , R. Ruiz-Villaverde","doi":"10.1016/j.semerg.2024.102352","DOIUrl":"10.1016/j.semerg.2024.102352","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102352"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.semerg.2024.102396
L. Vallejo Puntero, E. San Segundo Méndez, B.B. Báez Montiel
{"title":"Doctor: esta tos me está matando","authors":"L. Vallejo Puntero, E. San Segundo Méndez, B.B. Báez Montiel","doi":"10.1016/j.semerg.2024.102396","DOIUrl":"10.1016/j.semerg.2024.102396","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102396"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.semerg.2024.102345
F. Escobar Rabadán
{"title":"La valoración de la Medicina de Familia en el MIR","authors":"F. Escobar Rabadán","doi":"10.1016/j.semerg.2024.102345","DOIUrl":"10.1016/j.semerg.2024.102345","url":null,"abstract":"","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 2","pages":"Article 102345"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-09DOI: 10.1016/j.semerg.2024.102390
J.M. Fernández-García , A. Romero-Secin , M. Rubín-García
To analyze the evidence in the scientific literature that relates Long-Covid and obesity, a narrative review of articles published in English and Spanish in Medline and Embase in the last 5 years has been carried out. Infection with the SARS-CoV-2 virus causes a systemic inflammatory state increasing nutritional demand that favors sarcopenia in Long-Covid syndrome. It also causes endothelial dysfunction and a prothrombotic state that favors the formation of microthrombi and tissue hypoxia. A healthy and balanced diet is essential to treat obesity in addition to modifying the microbiota in Long-Covid and promoting physical and mental well-being. Obesity is an independent risk factor that increases the need for hospitalization, cardiovascular risk and mortality, as well as susceptibility to Long-Covid. Adipose tissue is a good reservoir of the virus, enhancing the comorbidities associated with obesity (high blood pressure, diabetes mellitus, dyslipidemia or fatty liver). There is insufficient evidence to recommend nutritional supplements to improve Long-Covid symptoms.
{"title":"Asociación entre obesidad y Long-Covid: una revisión narrativa","authors":"J.M. Fernández-García , A. Romero-Secin , M. Rubín-García","doi":"10.1016/j.semerg.2024.102390","DOIUrl":"10.1016/j.semerg.2024.102390","url":null,"abstract":"<div><div>To analyze the evidence in the scientific literature that relates Long-Covid and obesity, a narrative review of articles published in English and Spanish in Medline and Embase in the last 5<!--> <!-->years has been carried out. Infection with the SARS-CoV-2 virus causes a systemic inflammatory state increasing nutritional demand that favors sarcopenia in Long-Covid syndrome. It also causes endothelial dysfunction and a prothrombotic state that favors the formation of microthrombi and tissue hypoxia. A healthy and balanced diet is essential to treat obesity in addition to modifying the microbiota in Long-Covid and promoting physical and mental well-being. Obesity is an independent risk factor that increases the need for hospitalization, cardiovascular risk and mortality, as well as susceptibility to Long-Covid. Adipose tissue is a good reservoir of the virus, enhancing the comorbidities associated with obesity (high blood pressure, diabetes mellitus, dyslipidemia or fatty liver). There is insufficient evidence to recommend nutritional supplements to improve Long-Covid symptoms.</div></div>","PeriodicalId":53212,"journal":{"name":"Medicina de Familia-SEMERGEN","volume":"51 3","pages":"Article 102390"},"PeriodicalIF":0.9,"publicationDate":"2024-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号